MDPI and ACS Style
Bhat, Z.R.; Kumar, M.; Sharma, N.; Yadav, U.P.; Singh, T.; Joshi, G.; Pujala, B.; Raja, M.; Chatterjee, J.; Tikoo, K.;
et al. In Vivo Anticancer Evaluation of 6b, a Non-Covalent Imidazo[1,2-a]quinoxaline-Based Epidermal Growth Factor Receptor Inhibitor against Human Xenograft Tumor in Nude Mice. Molecules 2022, 27, 5540.
https://doi.org/10.3390/molecules27175540
AMA Style
Bhat ZR, Kumar M, Sharma N, Yadav UP, Singh T, Joshi G, Pujala B, Raja M, Chatterjee J, Tikoo K,
et al. In Vivo Anticancer Evaluation of 6b, a Non-Covalent Imidazo[1,2-a]quinoxaline-Based Epidermal Growth Factor Receptor Inhibitor against Human Xenograft Tumor in Nude Mice. Molecules. 2022; 27(17):5540.
https://doi.org/10.3390/molecules27175540
Chicago/Turabian Style
Bhat, Zahid Rafiq, Manvendra Kumar, Nisha Sharma, Umesh Prasad Yadav, Tashvinder Singh, Gaurav Joshi, Brahmam Pujala, Mohd Raja, Joydeep Chatterjee, Kulbhushan Tikoo,
and et al. 2022. "In Vivo Anticancer Evaluation of 6b, a Non-Covalent Imidazo[1,2-a]quinoxaline-Based Epidermal Growth Factor Receptor Inhibitor against Human Xenograft Tumor in Nude Mice" Molecules 27, no. 17: 5540.
https://doi.org/10.3390/molecules27175540